Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries

NCT07272577 | Recruiting

• 1 other identifier: 618
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to evaluate the efficacy of the erector spinae plane block (ESPB) on postoperative analgesia in patients undergoing laparoscopic abdominal surgeries.

Conditions

Erector Spinae Plane Block; Postoperative Analgesia; Laparoscopic Abdominal Surgeries

Outcome Measures

Primary Outcomes (1)

• Time to the 1st rescue analgesia

  Time to the first request for the rescue analgesia (time from the end of surgery to first dose of morphine administrated).

  24 hours postoperatively

Secondary Outcomes (5)

• Total morphine consumption

  24 hours postoperatively

• Mean arterial pressure

  Till the end of surgery (Up to 2 hours)

• Heart rate

  Till the end of surgery (Up to 2 hours)

• Degree of pain

  24 hours postoperatively

• Incidence of adverse events

  24 hours postoperatively

Study Arms (2)

Erector spinae plane block group

EXPERIMENTAL

Patients will receive an ultrasound-guided erector spinae plane block.

Other: Erector spinae plane block

Control group

NO INTERVENTION

The block will not be performed, and the patients will be shifted to the operation room.

Interventions

Erector spinae plane block OTHER

Patients will receive an ultrasound-guided erector spinae plane block.

Erector spinae plane block group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age ≥ 18 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status I-II.
• Body mass index (BMI) between 20-30 kg/m2.
• Patients undergoing laparoscopic abdominal surgeries under general anesthesia.

You may not qualify if:

• Bleeding or coagulation disorders.
• Having local sepsis, pre-existing.
• Peripheral neuropathies.
• Chronic pain conditions.
• Having any contraindication to regional anesthesia administration.
• Opioid dependency.
• Hypertension.
• Uncontrolled diabetes mellitus.

Sponsors & Collaborators

• Assiut University: lead

Study Sites (1)

Assiut University

Asyut, 71515, Egypt

RECRUITING

Central Study Contacts

Bahaa G Saad, MD

CONTACT

00201555590977; bahaagamal@aun.edu.eg

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt.

Study Record Dates

• First Submitted: November 27, 2025
• First Posted: December 9, 2025
• Study Start: December 10, 2025
• Primary Completion: April 1, 2026
• Study Completion: April 1, 2026
• Last Updated: December 11, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: After the end of study for one year.
• Access Criteria: The data will be available upon a reasonable request from the corresponding author

Locations

EG (1)